Heart failure, rhythm disorders and cardiovascular risk — the three areas where management has changed most in the last decade and where guidance dates fastest.
Titles cover acute and chronic heart failure, the four pillars of guideline-directed medical therapy and their realistic sequence of introduction in patients who will not tolerate rapid titration, cardiomyopathy, device selection and indication, arrhythmia management, anticoagulation decisions, and formal cardiovascular risk scoring.
The emphasis throughout is on the gap between what a trial demonstrated and what a clinic can deliver. Trial populations tolerate target doses; real patients frequently do not, and the judgement about what to compromise is rarely written down. These titles state the trial position, then address the patient in front of you. Risk scores referenced in the text can be calculated directly using the Academy’s free cardiology calculators.
Showing all 5 resultsSorted by price: high to low
